Emmaus Life Sciences Inc Asset Turnover Ratio (EMMAW), as of fourth quarter 2025, current and historic results, rankings and more - CSIMarket
CSIMarket Company Name, Ticker, Competitors, else..
 


• Sales per Employee
• Income per Employee
• Inventory Turnover
• Asset Turnover
• Receivables Turnover
Emmaus Life Sciences Inc   (EMMAW)
 

Emmaus Life Sciences Inc Asset Turnover Ratio

Quarterly Results, Trends, Rankings, Statistics

Emmaus Life Sciences Inc 's asset turnover ratio, the ratio that measures the ability of Emmaus Life Sciences Inc 's assets to generate revenue, sequentially decreased to 0.54 in the fourth quarter (Dec 31 2025), which does not come as a surprise, as the Emmaus Life Sciences Inc continue to experience difficult business climate.

Within sector 116 more businesses have achieved higher asset turnover ratio. While ranking the asset turnover ratio, among all other companies, it is fair to say, that the company's position has deteriorated in the fourth quarter 2025 compared to the preceding quarter from 2560 to 2681.

Asset Turnover Ratio Definition


Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

EMMAW Asset Turnover Ratio (Dec 31 2025)
IV. Quarter		 (Jun 30 2025)
II. Quarter		 (Mar 31 2025)
I. Quarter		 (Dec 31 2024)
IV. Quarter		 (Sep 30 2024)
III. Quarter
Y / Y Asset Change -18.35 % -3 % -19.44 % -32.04 % -43 %
Y / Y Revenue Change -29.68 % -47.61 % -3.99 % -54.04 % 9.17 %
Asset Turnover Ratio (TTM) 0.54 0.58 0.68 0.65 0.72
EMMAW's Total Ranking # 2681 # 2560 # 2739 # 2722 #
Seq. Asset Change -8.17 % 3.85 % -1.47 % -13.1 % 9.09 %
Seq. Revenue Change 36.74 % 17.08 % -22.16 % -43.57 % 1.88 %



Asset Turnover Ratio Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry # 117
Healthcare Sector # 393
Overall Market # 2681

Asset Turnover Ratio Statistics
High Average Low
25 11.27 2.82
(Dec 31 2020)   (Sep 30 2017)




EMMAW Company Profile • Back to EMMAW Efficiency Comparisons • Compare EMMAW Asset Turnover Ratio to its Competitors



Companies with similar Asset Turnover Ratio for the quarter ending Dec 31 2025, within Healthcare Sector Asset Turnover Ratio Revenues for 12 Months ending Dec 31 2025 Assets at quarter ending Dec 31 2025
Adm Tronics Unlimited Inc   1.55 $ 3.414  Millions$ 2.201  Millions
Cv Sciences Inc   1.54 $ 11.388  Millions$ 7.417  Millions
Chemed Corporation  1.53 $ 2,529.978  Millions$ 1,651.543  Millions
Kewaunee Scientific Corporation  1.53 $ 288.233  Millions$ 188.294  Millions
Koru Medical Systems Inc   1.52 $ 41.127  Millions$ 27.009  Millions
Medinotec Inc   1.51 $ 10.325  Millions$ 6.848  Millions
Marpai Inc  1.49 $ 18.099  Millions$ 12.109  Millions
Qhslab Inc   1.48 $ 2.692  Millions$ 1.821  Millions
Nephros Inc   1.46 $ 18.625  Millions$ 12.727  Millions
Aspira Women s Health inc   1.46 $ 8.915  Millions$ 6.101  Millions
Infusystem Holdings Inc  1.42 $ 143.436  Millions$ 101.143  Millions
Viemed Healthcare Inc   1.41 $ 270.280  Millions$ 191.049  Millions
Medpace Holdings Inc   1.41 $ 2,530.234  Millions$ 1,799.382  Millions
Aesthetic Medical International Holdings Group Limited  1.41 $ 106.636  Millions$ 75.867  Millions
Mimedx Group Inc   1.36 $ 416.672  Millions$ 305.793  Millions
Aveanna Healthcare Holdings Inc   1.34 $ 2,433.199  Millions$ 1,813.637  Millions
Evolus Inc   1.34 $ 297.107  Millions$ 221.757  Millions
Karyopharm Therapeutics Inc   1.34 $ 146.067  Millions$ 109.310  Millions
Longduoduo Co Ltd  1.34 $ 2.722  Millions$ 2.038  Millions
Xtant Medical Holdings Inc   1.33 $ 133.273  Millions$ 99.945  Millions
Star Equity Holdings Inc   1.32 $ 141.384  Millions$ 106.906  Millions
Vaxart Inc   1.32 $ 237.258  Millions$ 179.428  Millions
Evofem Biosciences Inc   1.32 $ 20.183  Millions$ 15.335  Millions
Elite Pharmaceuticals Inc   1.32 $ 138.547  Millions$ 105.341  Millions
Hims and Hers Health Inc   1.31 $ 2,347.378  Millions$ 1,789.326  Millions
Idexx Laboratories Inc  1.30 $ 4,303.579  Millions$ 3,320.489  Millions
Sanuwave Health Inc   1.29 $ 44.051  Millions$ 34.211  Millions
Electromed Inc   1.27 $ 68.064  Millions$ 53.417  Millions
Sonoma Pharmaceuticals Inc   1.27 $ 17.722  Millions$ 13.959  Millions
Rosecliff Acquisition Corp I  1.27 $ 20.547  Millions$ 16.202  Millions



Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.